In the news | 6th Sep 2022
How to avoid common pitfalls in the tech transfer process
Even the most well-established biotechnology companies can be challenged when it comes to implementing tech transfer successfully. Tech transfer processes bridge the gap between every stage of drug development for the transfer of information about development, manufacturing and quality assurance.
Read more on this topic in our article by Ken Forman, Senior Director of Product Strategy at IDBS, published in Labiotech.eu.
How to get more insight and value out of your Electronic Batch Record data with PIMS
Discover how PIMS can work synergistically with your existing Electronic Batch Record (EBR) software and why PIMS is a great alternative.
New process definition capabilities in PIMS further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers
New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
Tradeshow | European BioAnalysis Forum | Nov 2023
Speak to our experts to learn how an innovative approach to transform your bioanalytical operations and to improve data quality, productivity and compliance, according to industry standards such as ICH M10 standards
Software validation keeps GxP systems current and speeds up time-to-market
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.